The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
Open accessAbstract
RNA vaccines are efficient preventive measures to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. High levels of neutralizing SARS-CoV-2 antibodies are an important component of vaccine-induced immunity. Shortly after the initial two mRNA vaccine doses, the immunoglobulin G (IgG) response mainly consists of the proinflammatory subclasses IgG1 and IgG3. Here, we report that several months after the second vaccination, SARS-CoV-2–specific antibodies were increasingly composed of noninflammatory IgG4, which were further boosted by a third mRNA vaccination and/or SARS-CoV-2 variant breakthrough infections. IgG4 antibodies among all spike-specific IgG antibodies rose, on average, from 0.04% shortly after the second vaccination to 19.27% late after the third vaccination. This induction of IgG4 antibodies was not observed after homologous or heterologous SARS-CoV-2 vaccination with adenoviral vectors. Single-cell sequencing and flow cytometry revealed substantial frequencies of IgG4-switched B cells within the spike-binding memory B cell population [median of 14.4%; interquartile range (IQR) of 6.7 to 18.1%] compared with the overall memory B cell repertoire (median of 1.3%; IQR of 0.9 to 2.2%) after three immunizations. This class switch was associated with a reduced capacity of the spike-specific antibodies to mediate antibody-dependent cellular phagocytosis and complement deposition. Because Fc-mediated effector functions are critical for antiviral immunity, these findings may have consequences for the choice and timing of vaccination regimens using mRNA vaccines, including future booster immunizations against SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: A mathematical model explains saturating axon guidance responses to molecular gradients
Nguyen, H., Dayan, P., Pujic, Z., Cooper-White, J., & Goodhill, G. J. (2016) · eLife · doi:10.7554/elife.12248 · Cited by 1,221
RetractedIntegrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101765 · Cited by 2,527
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.-M., et al. (2021) · doi:10.1101/2021.12.14.21267615 · Cited by 2,420
Limb proportions show developmental plasticity in response to embryo movement
Pollard, A. S., Charlton, B. G., Hutchinson, J. R., Gustafsson, T., McGonnell, I. M., Timmons, J. A., & Pitsillides, A. A. (2017) · Scientific Reports · doi:10.1038/srep41926 · Cited by 2,364
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977
Perineuronal nets stabilize the grid cell network
Christensen, A. C., Lensjø, K. K., Lepperød, M. E., Dragly, S.-A., Sutterud, H., Blackstad, J. S., Fyhn, M., & Hafting, T. (2021) · Nature Communications · doi:10.1038/s41467-020-20241-w · Cited by 1,865
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00320-6 · Cited by 1,769
Lopez Bernal, J., Andrews, N., Gower, C., Robertson, C., Stowe, J., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ · doi:10.1136/bmj.n1088 · Cited by 1,389
Brochet, X., Lefranc, M.-P., & Giudicelli, V. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn316 · Cited by 1,216
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Mechanism and Regulation of Class Switch Recombination
Stavnezer, J., Guikema, J. E. J., & Schrader, C. E. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090248 · Cited by 1,132
Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M. C., & Wardemann, H. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.09.017 · Cited by 1,107
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Corbett, K. S., Flynn, B., Foulds, K. E., Francica, J. R., Boyoglu-Barnum, S., Werner, A. P., Flach, B., O’Connell, S., Bock, K. W., Minai, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024671 · Cited by 1,066
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Abu-Raddad, L. J., Chemaitelly, H., & Butt, A. A. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2104974 · Cited by 899
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science · doi:10.1126/science.abm0829 · Cited by 873
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Turner, J. S., O’Halloran, J. A., Kalaidina, E., Kim, W., Schmitz, A. J., Zhou, J. Q., Lei, T., Thapa, M., Chen, R. E., Case, J. B., et al. (2021) · Nature · doi:10.1038/s41586-021-03738-2 · Cited by 831
Malhotra, A., Walle, M., Paul, G. R., Kuhn, G. A., & Müller, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-81132-8 · Cited by 828
Immunoglobulin G4: an odd antibody
Aalberse, R. C., Stapel, S. O., Schuurman, J., & Rispens, T. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03207.x · Cited by 818
DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Aalberse, R. C., van der Gaag, R., & van Leeuwen, J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.722 · Cited by 736
Munro, A. P. S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02717-3 · Cited by 642
IgE Versus IgG4 Production Can Be Differentially Regulated by IL-10
Jeannin, P., Lecoanet, S., Delneste, Y., Gauchat, J.-F., & Bonnefoy, J.-Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3555 · Cited by 581
Mouse and human FcR effector functions
Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 579
Painter, M. M., Mathew, D., Goel, R. R., Apostolidis, S. A., Pattekar, A., Kuthuru, O., Baxter, A. E., Herati, R. S., Oldridge, D. A., Gouma, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.001 · Cited by 499
Röltgen, K., Nielsen, S. C. A., Silva, O., Younes, S. F., Zaslavsky, M., Costales, C., Yang, F., Wirz, O. F., Solis, D., Hoh, R. A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.018 · Cited by 469
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Ackerman, M. E., Moldt, B., Wyatt, R. T., Dugast, A.-S., McAndrew, E., Tsoukas, S., Jost, S., Berger, C. T., Sciaranghella, G., Liu, Q., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.016 · Cited by 450
Aalberse, R. C., & Schuurman, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01341.x · Cited by 449
Chung, A. W., Ghebremichael, M., Robinson, H., Brown, E., Choi, I., Lane, S., Dugast, A.-S., Schoen, M. K., Rolland, M., Suscovich, T. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007736 · Cited by 406
Germinal centre-driven maturation of B cell response to mRNA vaccination
Kim, W., Zhou, J. Q., Horvath, S. C., Schmitz, A. J., Sturtz, A. J., Lei, T., Liu, Z., Kalaidina, E., Thapa, M., Alsoussi, W. B., et al. (2022) · Nature · doi:10.1038/s41586-022-04527-1 · Cited by 345
Dispinseri, S., Secchi, M., Pirillo, M. F., Tolazzi, M., Borghi, M., Brigatti, C., De Angelis, M. L., Baratella, M., Bazzigaluppi, E., Venturi, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22958-8 · Cited by 344
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340
Heterogeneity of Human CD4 + T Cells Against Microbes
Sallusto, F. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112056 · Cited by 336
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
Richards, J. O., Karki, S., Lazar, G. A., Chen, H., Dang, W., & Desjarlais, J. R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0201 · Cited by 313
Mudd, P. A., Minervina, A. A., Pogorelyy, M. V., Turner, J. S., Kim, W., Kalaidina, E., Petersen, J., Schmitz, A. J., Lei, T., Haile, A., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.026 · Cited by 309
Interleukin 4 induces synthesis of IgE and IgG4 in human B cells
Lundgren, M., Persson, U., Larsson, P., Magnusson, C. G. M., Smith, C. I. E., Hammarström, L. L. G., & Gronowicz, E. S. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190724 · Cited by 304
Nordström, P., Ballin, M., & Nordström, A. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00089-7 · Cited by 302
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Muecksch, F., Wang, Z., Cho, A., Gaebler, C., Ben Tanfous, T., DaSilva, J., Bednarski, E., Ramos, V., Zong, S., Johnson, B., et al. (2022) · Nature · doi:10.1038/s41586-022-04778-y · Cited by 297
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
van Erp, E. A., Luytjes, W., Ferwerda, G., & van Kasteren, P. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00548 · Cited by 281
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., et al. (2021) · Nature · doi:10.1038/s41586-021-04060-7 · Cited by 275
Meslé, M. M., Brown, J., Mook, P., Hagan, J., Pastore, R., Bundle, N., Spiteri, G., Ravasi, G., Nicolay, N., Andrews, N., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.47.2101021 · Cited by 266
Wratil, P. R., Stern, M., Priller, A., Willmann, A., Almanzar, G., Vogel, E., Feuerherd, M., Cheng, C.-C., Yazici, S., Christa, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01715-4 · Cited by 253
Self-citationRegules, J. A., Cicatelli, S. B., Bennett, J. W., Paolino, K. M., Twomey, P. S., Moon, J. E., Kathcart, A. K., Hauns, K. D., Komisar, J. L., Qabar, A. N., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw237 · Cited by 216
Zingaropoli, M. A., Nijhawan, P., Carraro, A., Pasculli, P., Zuccalà, P., Perri, V., Marocco, R., Kertusha, B., Siccardi, G., Del Borgo, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627548 · Cited by 213
Fischinger, S., Fallon, J. K., Michell, A. R., Broge, T., Suscovich, T. J., Streeck, H., & Alter, G. (2019) · Journal of Immunological Methods · doi:10.1016/j.jim.2019.07.002 · Cited by 201
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Yamin, R., Jones, A. T., Hoffmann, H.-H., Schäfer, A., Kao, K. S., Francis, R. L., Sheahan, T. P., Baric, R. S., Rice, C. M., Ravetch, J. V., et al. (2021) · Nature · doi:10.1038/s41586-021-04017-w · Cited by 185
Impact of Inflammatory Cytokines on Effector and Memory CD8+ T Cells
Kim, M. T., & Harty, J. T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00295 · Cited by 171
Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching
Horns, F., Vollmers, C., Croote, D., Mackey, S. F., Swan, G. E., Dekker, C. L., Davis, M. M., & Quake, S. R. (2016) · eLife · doi:10.7554/elife.16578 · Cited by 152
Naranbhai, V., García-Beltrán, W. F., Chang, C. C., Berrios, C., Thierauf, J., Kirkpatrick, G., Onozato, M. L., Cheng, J., Denis, K. S., Lam, E. C., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab593 · Cited by 142
Kapłonek, P., Cizmeci, D., Fischinger, S., Collier, A.-R. Y., Suscovich, T. J., Linde, C., Broge, T. A., Mann, C. J., Amanat, F., Dayal, D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm2311 · Cited by 137
Hansen, C. H., Schelde, A. B., Moustsen-Helm, I. R., Emborg, H.-D., Krause, T. G., Mølbak, K., & Valentiner-Branth, P. (2021) · doi:10.1101/2021.12.20.21267966 · Cited by 133
Descatoire, M., Weller, S., Irtan, S., Sarnacki, S., Feuillard, J., Storck, S., Guiochon‐Mantel, A., Bouligand, J., Morali, A., Cohen, J., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132203 · Cited by 127
Mechanisms of allergen‐specific immunotherapy
Akdiş, C. A., & Blaser, K. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00120.x · Cited by 119
Regulation of C gamma subclass germ-line transcripts in human peripheral blood B cells.
Kitani, A., & Strober, W. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3478 · Cited by 115
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2
Tenbusch, M., Schumacher, S., Vogel, E., Priller, A., Held, J., Steininger, P. A., Beileke, S., Irrgang, P., Brockhoff, R. A., Salmanton‐García, J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00420-5 · Cited by 115
Self-citationBoonpiyathad, T., Meyer, N., Moniuszko, M., Sokołowska, M., Eljaszewicz, A., Wirz, O. F., Tomasiak, M. M., Bodzenta‐Łukaszyk, A., Ruxrungtham, K., & van de Veen, W. (2016) · Allergy · doi:10.1111/all.12966 · Cited by 111
Yates, J. L., Ehrbar, D. J., Hunt, D., Girardin, R. C., Dupuis, A. P., Payne, A. F., Sowizral, M., Varney, S. D., Kulas, K. E., Demarest, V. L., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100329 · Cited by 108
Class Switch Recombination: A Comparison Between Mouse and Human
Pan‐Hammarström, Q., Zhao, Y., & Hammarström, L. L. G. (2007) · Advances in immunology · doi:10.1016/s0065-2776(06)93001-6 · Cited by 104
The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients
Luo, H., Jia, T., Chen, J., Zeng, S., Qiu, Z., Wu, S., Li, X., Lei, Y., Wang, X., Wu, W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632814 · Cited by 97
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Boudreau, C. M., & Alter, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00440 · Cited by 91
Zohar, T., Hsiao, J. C., Mehta, N., Das, J., Devadhasan, A., Karpinski, W., Callahan, C., Citron, M. P., DiStefano, D. J., Touch, S., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.11.006 · Cited by 83
Chaudhury, S., Ockenhouse, C. F., Regules, J. A., Dutta, S., Wallqvist, A., Jongert, E., Waters, N. C., Lemiale, F., & Bergmann‐Leitner, E. S. (2016) · Malaria Journal · doi:10.1186/s12936-016-1348-9 · Cited by 81
den Hoecke, S. V., Ehrhardt, K., Kolpe, A. B., Bakkouri, K. E., Deng, L., Grootaert, H., Schoonooghe, S., Smet, A., Bentahir, M., Roose, K., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02500-16 · Cited by 77
Self-citationAssessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
Moura, A. D., da Costa, H. H. M., Correa, V. A., Lima, A. K. D. S., Lindoso, J. Â. L., Gaspari, E. D., Hong, M. A., Cunha-Junior, J. P., & Prudêncio, C. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-95045-z · Cited by 76
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Farkash, I., Feferman, T., Saban, N. C., Avraham, Y., Morgenstern, D., Mayuni, G., Barth, N., Lustig, Y., Miller, L., Shouval, D. S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110114 · Cited by 61
de Jong, B. G., IJspeert, H., Marques, L., van der Burg, M., van Dongen, J. J. M., Loos, B. G., & van Zelm, M. C. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.43 · Cited by 54
A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors
Corrales‐Aguilar, E., Trilling, M., Reinhard, H., Mercé-Maldonado, E., Widera, M., Schaal, H., Zimmermann, A., Mandelboim, O., & Hengel, H. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.09.006 · Cited by 52
Self-citationUllah, I., Beaudoin-Bussières, G., Symmes, K., Cloutier, M., Ducas, É., Tauzin, A., Laumaea, A., Grunst, M. W., Dionne, K., Richard, J., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100893 · Cited by 52
Kibler, A., Budeus, B., Homp, E., Bronischewski, K., Berg, V., Sellmann, L., Murke, F., Heinold, A., Heinemann, F. M., Lindemann, M., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201952 · Cited by 47
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
Lapuente, D., Maier, C., Irrgang, P., Hübner, J., Peter, A. S., Hoffmann, M., Ensser, A., Ziegler, K., Winkler, T., Birkholz, T., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04072-7 · Cited by 38
Self-citationSerum IgG4 level predicts COVID-19 related mortality
Della‐Torre, E., Lanzillotta, M., Strollo, M., Ramirez, G. A., Dagna, L., & Tresoldi, M. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.09.012 · Cited by 37
Vogel, E., Kocher, K., Priller, A., Cheng, C., Steininger, P. A., Liao, B., Körber, N., Willmann, A., Irrgang, P., Held, J., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104294 · Cited by 36
Self-citationStable Drosophila Cell Lines: An Alternative Approach to Exogenous Protein Expression
Backović, M., & Krey, T. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3043-2_17 · Cited by 34
Self-citationVaquero, S. T., de Campos‐Mata, L., Ramada, J. M., Díaz, P., Navarro‐Barriuso, J., Ribas‐Llauradó, C., Melero, N. R., Carolis, C., Cerutti, A., Gimeno, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.737083 · Cited by 34
Zhu, D. Y., Gorman, M. J., Yuan, D., Yu, J., Mercado, N. B., McMahan, K., Borducchi, E. N., Lifton, M. A., Liu, J., Nampanya, F., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001609 · Cited by 18
Acevedo, O. A., Díaz, F. E., Beals, T. E., Benavente, F. M., Soto, J. A., Escobar‐Vera, J., González, P. A., & Kalergis, A. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00075 · Cited by 13
Cited by
The Unique Properties of IgG4 and Its Roles in Health and Disease
Rispens, T., & Huijbers, M. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00871-z · Cited by 282
Metadata
- Authors
- Irrgang, P., Gerling, J., Kocher, K., Lapuente, D., Steininger, P., Habenicht, K., Wytopil, M., Beileke, S., Schäfer, S., Zhong, J., Ssebyatika, G., Krey, T., Falcone, V., Schülein, C., Peter, A. S., Nganou-Makamdop, K., Hengel, H., Held, J., Bogdan, C., Überla, K., Schober, K., Winkler, T. H., & Tenbusch, M.
- Venue
- Science Immunology
- Published
- 2023-01-27
- Volume
- 8
- Issue
- 79
- Pages
- eade2798-eade2798
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W4312113923
- Cited by
- 264
- References
- 86
- FWCI
- 25.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.